Stockreport

Amylyx Pharmaceuticals Says 2026 Could Be “Transformative” Ahead of Avexitide Phase 3 Readout [Yahoo! Finance]

Amylyx Pharmaceuticals, Inc.  (AMLX) 
PDF Amylyx Pharmaceuticals (NASDAQ:AMLX) executives outlined a slate of milestones they expect to shape the company's near-term trajectory during TD Cowen's 46th Annual Hea [Read more]